[1]
D. Antono and A. Sulaksana, “Cost Effectiveness Kemoterapi Kombinasi Neoadjuvant Cisplatin Paclitaxel Dibanding Cisplatin Flourourasil terhadap Respon Klinis pada Karsinoma Nasofaring”, Medica Hospitalia J. Clin. Med., vol. 2, no. 3, Sep. 2017.